1. The comparison of 3D printing surgical guide and traditional occlusal splint in the treatment with facial asymmetry cases
Ming CAI ; Yusheng YANG ; Xudong WANG ; Biao LI ; Shunyao SHEN ; Tengfei JIANG ; Guofang SHEN
Chinese Journal of Plastic Surgery 2018;34(6):417-421
Objective:
To compare the surgical accuracy of the 3D printing surgical guide and traditional occlusal splint in the treatment of skeletal facial asymmetry cases.
Methods:
12 facial asymmetric patients underwent joint orthognathic and orthodontics treatments were included in this research. In the 3D printing group (
2.Clinical application and accuracy of the genioplasty surgical templates system for osseous genioplasty
Biao LI ; Hongpu WEI ; Tengfei JIANG ; Shunyao SHEN ; Guofang SHEN ; Xudong WANG
Chinese Journal of Stomatology 2016;51(11):646-650
Objective To develop and validate a new genioplasty templates system for monoblock osseous genioplasty.Methods Thirty-six patients with chin deformities were enrolled in this study.The chin template system included a cutting guide and a repositioning guide for a genioplasty.Chin templates were designed in a computer and fabricated using a three-dimensional printing technique.The accuracy of the genioplasty templates were assessed by comparing the actual postoperative outcomes with the virtual plan.Results All genioplasty was successfully completed by the template system.The largest linear rootmean-square deviation(RMSD) between the planned and the postoperative chin segments was 1.16 mm and the largest angular RMSD was 3.06°.Conclusions The results showed that the chin template system provides a reliable method for transfer of genioplasty planning.The operation precision of the genioplasty can be improved by using the surgical templates system.
3.Comparison between computer aided simulation and dental model orthognathic surgery for the treatment of patients with mandibular excess and facial asymmetries
Shunyao SHEN ; Tiantian CHEN ; Chenpei LU ; Tengfei JIANG ; Xudong WANG ; Guofang SHEN
Chinese Journal of Stomatology 2016;51(11):651-655
Objective To evaluate the results of the orthognathic surgery with computer aided simulation-three-dimensional(3D) printed surgical guide and dental model surgery in the treatmemt of patients with mandibular excess and facial asymmetries.Methods The coordinate system was built in ProPlan CMF 2.0 software,and the horizontal plane consisted of PoL,PoR,OrL,middle sagittal plane through nasion point and basion point and the plane perpendicular to the horizontal plane,coronoid plane through nasion point and the plane perpendicular to the horizontal plane and middle sagittal plane.The orientation of maxilla and mandibular distal segment was calculated by each triangle(U 1-U6L-U6R,L1-L6L-L6R,Me-M5L-M5R) before and after orthognathic surgery.A total of 60 mandibular excess patients with facial asymmetries were enrolled in this retrospective study.They were divided into two groups,group I with computer aided simulation,group Ⅱ with dental model surgery.The difference of maxillary occlusal plane roll and yaw angle,mandibular occlusal plane roll and yaw angle,and mandibular body plane roll and yaw angle were calculated.Statistical analysis was performed with SPSS 17.0 software.Results The yaw angle of mandibular occlusal plane of the dental model surgery and computer aided simulation was 0.36°± 0.48° and 0.84° ±0.36° (P=0.043),respectively.The roll angle of mandibular occlusal plane of the dental model surgery and computer aided simulation was 0.26°±0.79° and 0.54°±0.40°(P=0.032),respectively.The yaw angle of mandibular body plane of the dental model surgery and computer aided simulation was 0.60°± 1.04° and 0.23°±0.52°(P=0.008),respectively.The roll angle of mandibular body plane of the dental model surgery and computer aided simulation was 0.82°± 0.72° and 0.53°± 0.37° (P=0.028),respectively.The changes in computer aided simulation group were more obvious than that in the dental model surgery group,but the difference was not significant in the yaw angle of maxillary occlusal plane and the roll angle of maxillary occlusal plane between the two groups(P > 0.05).Conclusions It was more effective to correct mnandibular asymmetry by computer aided simulation than dental model surgery.
4.A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence.
Tao HE ; Mingxing HU ; Shunyao ZHU ; Meiling SHEN ; Xiaorong KOU ; Xiuqi LIANG ; Lu LI ; Xinchao LI ; Miaomiao ZHANG ; Qinjie WU ; Changyang GONG
Acta Pharmaceutica Sinica B 2023;13(2):804-818
Neoadjuvant chemotherapy has become an indispensable weapon against high-risk resectable cancers, which benefits from tumor downstaging. However, the utility of chemotherapeutics alone as a neoadjuvant agent is incapable of generating durable therapeutic benefits to prevent postsurgical tumor metastasis and recurrence. Herein, a tactical nanomissile (TALE), equipped with a guidance system (PD-L1 monoclonal antibody), ammunition (mitoxantrone, Mit), and projectile bodies (tertiary amines modified azobenzene derivatives), is designed as a neoadjuvant chemo-immunotherapy setting, which aims at targeting tumor cells, and fast-releasing Mit owing to the intracellular azoreductase, thereby inducing immunogenic tumor cells death, and forming an in situ tumor vaccine containing damage-associated molecular patterns and multiple tumor antigen epitopes to mobilize the immune system. The formed in situ tumor vaccine can recruit and activate antigen-presenting cells, and ultimately increase the infiltration of CD8+ T cells while reversing the immunosuppression microenvironment. Moreover, this approach provokes a robust systemic immune response and immunological memory, as evidenced by preventing 83.3% of mice from postsurgical metastasis or recurrence in the B16-F10 tumor mouse model. Collectively, our results highlight the potential of TALE as a neoadjuvant chemo-immunotherapy paradigm that can not only debulk tumors but generate a long-term immunosurveillance to maximize the durable benefits of neoadjuvant chemotherapy.